Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma To Present Long-Term Follow-Up Data On Unloxcyt

BRIEF-Sun Pharma To Present Long-Term Follow-Up Data On Unloxcyt

- Sun Pharmaceutical Industries Ltd SUN.NS:

  • SUN PHARMA - TO PRESENT LONG-TERM FOLLOW-UP DATA ON UNLOXCYT

  • SUN PHARMA - NEARLY 27% OF PATIENTS EXPERIENCED A COMPLETE RESPONSE

  • SUN PHARMA - ONLY 1 PATIENT EXPERIENCED A GRADE >3 IMMUNE-RELATED ADVERSE EVENT

Source text: ID:nBSE6Jx299

Further company coverage: SUN.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news